Omega Diagnostics Group (ODX)

 

ODX Share PerformanceMore

52 week high21.00 08/08/16
52 week low13.75 30/03/16
52 week change 3.88 (27.19%)
4 week volume2,570,466 22/12/16

Media for (ODX)

Presenter: Kieron Harbinson, Group Finance Director
06/07/2015
Presenter: Kieron Harbinson, Group Finance Director
14/04/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

ISO accreditation for manufacturing facility

RNS Number: 8340T Omega Diagnostics Group PLC 11 January 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") ISO accreditation for manufacturing facility in Pune, India Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that its fully owned Indian subsidiary, Omega Dx (...

Hardman Research: Food intolerance driving growth

RNS Number: 3552Q Omega Diagnostics Group PLC 29 November 2016 Hardman Research: Food intolerance driving growth Food intolerance driving growth: Omega Diagnostics Group has an established core business providing high quality in vitro diagnostic tests within three core areas of competence - Food Intolerance, Allergy & Autoimmune, Infectious Disease - ...

Holding(s) in Company

RNS Number: 0327Q Omega Diagnostics Group PLC 24 November 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Omega Diagnostics Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of...

Omega Diagnostics improves H1 pretax profit

Omega Diagnostics has improved its H1 pretax profit to 305,447, from 177,360.

Half-year Report

RNS Number: 6304P Omega Diagnostics Group PLC 21 November 2016 21 November 2016 OMEGA DIAGNOSTICS GROUP PLC ("Omega" or the "Company" or the "Group") INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2016 Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disea...

Hardman Research: Diagnosing growth opportunities

RNS Number: 7909N Omega Diagnostics Group PLC 31 October 2016 Hardman Research: Diagnosing growth opportunities Diagnosing growth opportunities: Omega Diagnostics Group has an established core business providing high quality in vitro diagnostic tests within three core areas of competence - Food Intolerance, Allergy & Autoimmune, Infectious Disease - tha...

Trading Update and Notice of Interim Results

RNS Number: 6304M Omega Diagnostics Group PLC 17 October 2016 Omega Diagnostics Group PLC ("Omega" or "the Company") Trading Update and Notice of Interim Results Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces the following trading update for the six months to 30 September...

Result of AGM

RNS Number: 8212G Omega Diagnostics Group PLC 10 August 2016 Omega Diagnostics Group PLC ("Omega" or the "Company") Result of Annual General Meeting Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that at the Annual General Meeting held earlier today, all resolutions were du...

Fundamental DataMore

P/E ratio36.25
EPS0.5
Dividend yield0 %

Equity Research (ODX)

hardman & co
Omega Diagnostics Group PLC
29/11/2016
Omega Diagnostics Group has an established core business providing high quality in vitro diagnostic tests within three core areas of competence – Food Intolerance, Allergy & Autoimmune,...
edison investment research
Omega Diagnostics Group PLC
05/04/2016
Edison Investment Research is terminating coverage on Omega Diagnostics Group plc (ODX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts...
edison investment research
Omega Diagnostics Group PLC
05/04/2016
Edison Investment Research is terminating coverage on Omega Diagnostics Group plc (ODX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts...

Latest discussion posts More

  • News to come

    Today III is going to tell us that ODX produced its first malaria test and also that the PUNE facility got its accreditation which means ODX can start selling its diagnostics ...
    11-Jan-2017
    Ambiorix1
  • Good news re the new Inidian facility

    and the first commercial malaria sales have been achieved: Http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/ODX/13091477.html "ISO ...
    11-Jan-2017
    gretel
  • Nice mention here

    Nice mention ...
    25-Nov-2016
    gretel

Users' HoldingsMore

Users who hold Omega Diagnostics Group also hold..
LLOYDS GRP.35%
SAINSBURY(J)23%
IQE23%
TAYLOR WIMPEY17%
CENTRICA17%

Codes & Symbols

ISINGB00B1VCP282
SymbolsODX, LSE:ODX, ODX.L, ODX:LN, LON:ODX, XLON:ODX